Episode

Advances in Payload Delivery and Drug Conjugation

Podcast
PharmaTalkRadio
Published
Dec 12, 2025
Duration seconds
1799
Processing state
not_requested
Canonical source
https://www.spreaker.com/episode/advances-in-payload-delivery-and-drug-conjugation--69004173
Audio
https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/69004173/podd_2025_payload_delivery_podcast.mp3
JSON
/v1/public/podcasts/pharmatalkradio-7131046/episodes/advances-in-payload-delivery-and-drug-conjugation
Markdown
/podcast/pharmatalkradio-7131046/advances-in-payload-delivery-and-drug-conjugation.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/advances-in-payload-delivery-and-drug-conjugation/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/pharmatalkradio-7131046/advances-in-payload-delivery-and-drug-conjugation.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address: Biological and chemical challenges for these therapies Building out scalable manufacturing and a regulatory strategy Hurdles to overcome to get products to market To learn more about the PODD Conference, please visit Drug-Delivery.org .